Open help menu
Live Webinar

Legal-Looking but Risky Business: Gas Station, Convenience Store, and Online “Highs” — What Providers and the Public Need to Know

Timothy Gooden, MD
|

Information

Date & Time

Description

The one-hour presentation titled "Current Use of Novel Psychoactive Drugs Across the US" provides a comprehensive overview of novel psychoactive drugs (NPDs) in the United States. Participants will explore what defines these substances, delve into current usage statistics and demographic influences, and examine the physiological and psychological risks and benefits associated with NPDs. Additionally, the course will cover the evolving legal landscape and its implications for healthcare, as well as the clinical challenges in diagnosing and treating patients affected by these drugs.

Learning Objectives

Participants will be able to:

  • Define and classify novel psychoactive substances (NPS) commonly encountered in the United States, including synthetic cannabinoids, synthetic cathinones, designer opioids, and novel benzodiazepines.

  • Describe current epidemiologic patterns of NPS use in the US, including key demographic groups at risk and notable regional trends relevant to primary care practice.

  • Recognize clinical presentations, toxicities, and complications associated with major classes of NPS in outpatient and urgent-care settings.

  • Apply evidence-informed approaches to screening, brief assessment, and initial management of patients using or suspected of using NPS in the primary care setting.

  • Utilize appropriate referral, harm-reduction, and patient-education strategies to improve safety, engagement in care, and linkage to addiction or mental health services for patients affected by NPS use.

Educational Goal

The educational goals of this presentation are to equip healthcare professionals with a thorough understanding of novel psychoactive drugs, including their definitions, prevalence, and health effects. Participants will also gain insights into the legal landscape surrounding these substances and their implications for patient care and treatment strategies.

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Nurse
  • Physician
  • Psychologist
  • Social Worker

Presenters

Timothy Gooden, MD
Dr. Tim Gooden is Medical Director of Twelve Oaks Recovery Center in Navarre, Florida and Sabal Palms recovery Center in Brooksville, Florida. He is Board Certified in Pediatrics and Addiction Medicine, is a fellow of the American Academy of Pediatrics and the American Society of Addiction Medicine, as well as a diplomate of the American Board of Preventative Medicine, Addiction Medicine specialty. He has an interest in childhood trauma and its impact on adult function.

Financially Sponsored By

  • Acadia Healthcare Treatment Placement Specialists® (TPS)